Literature DB >> 25243197

Adult Acute Myeloid Leukemia Long-term Survivors.

M Jennifer Cheng1, Christopher S Hourigan1, Thomas J Smith1.   

Abstract

The number of leukemia patients and survivors is growing. This review summarizes what is known regarding the health related quality of life (HRQOL) and medical complications associated with acute myeloid leukemia (AML) disease and treatment and highlights understudied aspects of adult AML survivorship care, and potential novel areas for intervention.

Entities:  

Year:  2014        PMID： 25243197      PMCID： PMC4167020          DOI： 10.4172/2329-6917.1000135

Source DB:  PubMed          Journal:  J Leuk (Los Angel)        ISSN： 2329-6917


  82 in total

Review 1.  Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia.

Authors:  Francesco Buccisano; Luca Maurillo; Maria Ilaria Del Principe; Giovanni Del Poeta; Giuseppe Sconocchia; Francesco Lo-Coco; William Arcese; Sergio Amadori; Adriano Venditti
Journal:  Blood       Date:  2011-10-28       Impact factor: 22.113

Review 2.  Exercise interventions on health-related quality of life for people with cancer during active treatment.

Authors:  Shiraz I Mishra; Roberta W Scherer; Claire Snyder; Paula M Geigle; Debra R Berlanstein; Ozlem Topaloglu
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

3.  Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome.

Authors:  Christina A Meyers; Maher Albitar; Elihu Estey
Journal:  Cancer       Date:  2005-08-15       Impact factor: 6.860

4.  Caregiving as a risk factor for mortality: the Caregiver Health Effects Study.

Authors:  R Schulz; S R Beach
Journal:  JAMA       Date:  1999-12-15       Impact factor: 56.272

5.  Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study.

Authors:  Per Ljungman; Hareth Nahi; Annika Linde
Journal:  Br J Haematol       Date:  2005-07       Impact factor: 6.998

6.  Fatigue as an important aspect of quality of life in patients with acute myeloid leukemia.

Authors:  Andrea Schumacher; Dieter Wewers; Achim Heinecke; Cristina Sauerland; Olaf M Koch; Jürgen van de Loo; Thomas Büchner; Wolfgang E Berdel
Journal:  Leuk Res       Date:  2002-04       Impact factor: 3.156

7.  Distress, problems and supportive care needs of patients treated with auto- or allo-SCT.

Authors:  A M J Braamse; B van Meijel; O Visser; P C Huijgens; A T F Beekman; J Dekker
Journal:  Bone Marrow Transplant       Date:  2013-10-07       Impact factor: 5.483

8.  Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia.

Authors:  Dorle Messerer; Jutta Engel; Joerg Hasford; Markus Schaich; Gerhard Ehninger; Cristina Sauerland; Thomas Büchner; Andrea Schumacher; Rainer Krahl; Dietger Niederwieser; Jürgen Krauter; Arnold Ganser; Ursula Creutzig; Hartmut Döhner; Richard F Schlenk
Journal:  Haematologica       Date:  2008-05-10       Impact factor: 9.941

Review 9.  Physical and psychosocial benefits of yoga in cancer patients and survivors, a systematic review and meta-analysis of randomized controlled trials.

Authors:  Laurien M Buffart; Jannique G Z van Uffelen; Ingrid I Riphagen; Johannes Brug; Willem van Mechelen; Wendy J Brown; Mai J M Chinapaw
Journal:  BMC Cancer       Date:  2012-11-27       Impact factor: 4.430

10.  Impact of influenza-like illness and effectiveness of influenza vaccination in oncohematological children who have completed cancer therapy.

Authors:  Susanna Esposito; Valerio Cecinati; Barbara Scicchitano; Giovanni Carlo Delvecchio; Nicola Santoro; Doriana Amato; Claudio Pelucchi; Momcilo Jankovic; Domenico De Mattia; Nicola Principi
Journal:  Vaccine       Date:  2009-12-08       Impact factor: 3.641
View more
  9 in total

Review 1.  Advancing the Minimal Residual Disease Concept in Acute Myeloid Leukemia.

Authors:  Peter Hokland; Hans B Ommen; Matthew P Mulé; Christopher S Hourigan
Journal:  Semin Hematol       Date:  2015-04-07       Impact factor: 3.851

2.  Styryl quinazolinones and its ethynyl derivatives induce myeloid differentiation.

Authors:  Sridhar Radhakrishnan; Riyaz Syed; Hisashi Takei; Ikei S Kobayashi; Eugene Nakamura; Farheen Sultana; Ahmed Kamal; Daniel G Tenen; Susumu S Kobayashi
Journal:  Bioorg Med Chem Lett       Date:  2019-06-20       Impact factor: 2.823

3.  Outcome and late effects among acute myeloid leukemia survivors: a nationwide population-based study.

Authors:  Kuang-Hsi Chang; Wen-Li Hwang; Chih-Hsin Muo; Chung Y Hsu; Chieh-Lin Jerry Teng
Journal:  Support Care Cancer       Date:  2016-08-09       Impact factor: 3.603

4.  Anti-CD123 antibody-modified niosomes for targeted delivery of daunorubicin against acute myeloid leukemia.

Authors:  Fu-Rong Liu; Hui Jin; Yin Wang; Chen Chen; Ming Li; Sheng-Jun Mao; Qiantao Wang; Hui Li
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

5.  Personalizing Chinese medicine by integrating molecular features of diseases and herb ingredient information: application to acute myeloid leukemia.

Authors:  Lin Huang; Haichang Li; Duoli Xie; Tieliu Shi; Chengping Wen
Journal:  Oncotarget       Date:  2017-06-27

6.  Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.

Authors:  Yunan Li; Mingying Zhang; Mengyao Sheng; Peng Zhang; Zizhen Chen; Wen Xing; Jie Bai; Tao Cheng; Feng-Chun Yang; Yuan Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2018-03-28       Impact factor: 4.553

Review 7.  Progress and Challenges in Survivorship After Acute Myeloid Leukemia in Adults.

Authors:  Ginna Granroth; Nandita Khera; Cecilia Arana Yi
Journal:  Curr Hematol Malig Rep       Date:  2022-09-19       Impact factor: 4.213

8.  Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor Study.

Authors:  Saro H Armenian; Yanjun Chen; Lindsay Hageman; Jessica Wu; Wendy Landier; Alysia Bosworth; Liton Francisco; Elizabeth Schlichting; Ravi Bhatia; Donna Salzman; F Lennie Wong; Daniel J Weisdorf; Stephen J Forman; Mukta Arora; Smita Bhatia
Journal:  J Clin Oncol       Date:  2022-06-22       Impact factor: 50.717

9.  Cost Effectiveness of Midostaurin in the Treatment of Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia in the United States.

Authors:  Eytan Stein; Jipan Xie; Emilie Duchesneau; Subrata Bhattacharyya; Umakanth Vudumula; Briana Ndife; Gaetano Bonifacio; Annie Guerin; Nanxin Li; George Joseph
Journal:  Pharmacoeconomics       Date:  2019-02       Impact factor: 4.558
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.